Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
Tumors accumulate metabolites that deactivate infiltrating immune cells and polarize them toward anti-inflammatory phenotypes. We provide a comprehensive review of the complex networks orchestrated by several of the most potent immunosuppressive metabolites, highlighting the impact of adenosine, kyn...
Saved in:
Main Authors: | David Munn, Maria Rain Jennings, John Blazeck |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-10-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/10/e003013.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunization Program Implementation as the Effort to Achieve Universal Child Immunization (UCI)
by: Fikri
Published: (2023-11-01) -
WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis
by: Weiliang Jiang, et al.
Published: (2025-02-01) -
Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
by: Jiongli Pan, et al.
Published: (2025-02-01) -
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
by: Shivan Sivakumar, et al.
Published: (2025-02-01) -
Post-translational modifications as a key mechanism for herpes simplex virus type I evasion of host innate immunity
by: Yongxing Zhang, et al.
Published: (2025-02-01)